Forte Biosciences, Inc.FBRXNASDAQ

Revenue (LTM)

Net Income (LTM)

$-35M

-12.7% YoY

Free Cash Flow

$-31M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	-0	-0↑33.3%	0	-0	-0↓333.3%
Operating Income	-14	-21↓51.0%	-14↑35.3%	-32↓133.8%	-37↓12.7%
Net Income	-46	-22↑53.3%	-14↑36.1%	-31↓127.1%	-35↓12.7%
EBITDA	-46	-21↑53.8%	-14↑35.4%	-32↓134.3%	-35↓9.1%
EPS Diluted	-157.93	-38.85↑75.4%	-19.96↑48.6%	-24.92↓24.8%	-12.17↑51.2%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	59	42↓28.5%	41↓2.2%	12↓70.9%	22↑86.0%
Total Current Assets	60	43↓29.0%	42↓2.4%	38↓7.7%	61↑60.1%
Total Assets	61	43↓29.3%	42↓3.0%	39↓7.2%	62↑57.9%
Total Current Liabilities	2	2↓22.2%	3↑80.8%	4↑15.3%	9↑147.7%
Total Liabilities	2	2↓22.2%	3↑80.8%	4↑15.3%	9↑147.7%
Total Equity	59	42↓29.6%	39↓6.6%	35↓9.0%	52↑48.6%
Total Debt	0	0	0	0	0
Net Debt	-59	-42↑28.5%	-41↑2.2%	-12↑70.9%	-22↓86.0%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-18	-17↑9.5%	-8↑50.9%	-29↓250.7%	-31↓7.1%
Capital Expenditure	0	0	0	-0	-0↑58.0%
Free Cash Flow	-18	-17↑9.5%	-8↑50.9%	-29↓251.8%	-31↓6.9%
Stock-Based Comp	1	4↑340.8%	4↓4.7%	3↓18.2%	3↓5.8%
Net Change in Cash	52	-17↓132.3%	-1↑94.4%	-4↓321.1%	-15↓274.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance